Bosch FX - Search Results

1

[p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].

Bosch FX, Homann N, Conradt C, Dietz A, Erber R. Bosch FX, et al. HNO. 1999 Sep;47(9):833-48. doi: 10.1007/s001060050470. HNO. 1999. PMID: 10525616 Review. German. No abstract available.

2

[Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].

Homann N, Andl T, Nees M, Schuhmann A, Herold-Mende C, Bosch FX. Homann N, et al. Among authors: bosch fx. HNO. 1993 May;41(5):254-60. HNO. 1993. PMID: 8392993 German.

3

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.

Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H, Bosch FX. Erber R, et al. Among authors: bosch fx. Oncogene. 1998 Apr 2;16(13):1671-9. doi: 10.1038/sj.onc.1201690. Oncogene. 1998. PMID: 9582015

4

[Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].

Haas S, Bosch FX, Klein-Kühne W, Nollert J, Rudat V, Conradt C, Dietz A. Haas S, et al. Among authors: bosch fx. HNO. 1999 Sep;47(9):777-86. doi: 10.1007/s001060050460. HNO. 1999. PMID: 10525606 Clinical Trial. German.

5

[The role of oncogenic human papillomaviruses in tonsillar squamous cell carcinomas with functional inactivation of the retinoblastoma protein].

Helbig M, Andl T, Kahn T, Klein-Kühne W, Conradt C, Dietz A, Bosch FX. Helbig M, et al. Among authors: bosch fx. HNO. 1999 Sep;47(9):796-803. doi: 10.1007/s001060050462. HNO. 1999. PMID: 10525608 German.

6

[Detection of numerical chromosome aberrations in leukoplakia and squamous epithelial carcinomas of the head-neck area using fluorescence in situ hybridization].

Lenz C, Dietz A, Pfuhl A, Finckh M, Conradt C, Weidauer H, Bosch FX. Lenz C, et al. Among authors: bosch fx. HNO. 2000 May;48(5):367-71. doi: 10.1007/s001060050582. HNO. 2000. PMID: 10872117 German.

7

Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.

Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX. Homann N, et al. Among authors: bosch fx. Clin Cancer Res. 2001 Feb;7(2):290-6. Clin Cancer Res. 2001. PMID: 11234882

8

[Gene therapy with p53 tumor suppressors].

Dietz A, Esser D, Helbig M, Bosch FX. Dietz A, et al. Among authors: bosch fx. HNO. 2003 May;51(5):365-8. doi: 10.1007/s00106-003-0850-x. Epub 2003 Apr 15. HNO. 2003. PMID: 12835851 German. No abstract available.

9

[Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].

Kunz C, Bosch FX, Klein-Kühne W, Nollert J, Rudat V, Conradt C, Dietz A. Kunz C, et al. Among authors: bosch fx. HNO. 2003 Oct;51(10):800-5. doi: 10.1007/s00106-003-0818-x. Epub 2003 Apr 9. HNO. 2003. PMID: 14523533 German.

10

Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck.

Soder AI, Hopman AH, Ramaekers FC, Conradt C, Bosch FX. Soder AI, et al. Among authors: bosch fx. Cancer Res. 1995 Nov 1;55(21):5030-7. Cancer Res. 1995. PMID: 7585547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters